Alimera Sciences

Manufacturing · Georgia, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

6120 Windward Pkwy Ste 290, Alpharetta, ...

Revenue

$8 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Alimera Sciences

Alimera Sciences is a global pharmaceutical company dedicated to developing innovative therapies that improve vision in chronic retinal diseases. The company focuses on conditions affecting the posterior segment of the eye, particularly the retina, aiming to address the inadequacies of current treatments that impact millions in an aging population. Alimera strives to help patients see better for longer with fewer treatments by collaborating with the medical community and patient associations. Their mission is to be invaluable to patients, doctors, and partners concerned with retinal health.Explore more
Alimera Sciences's Social MediaPopular SearchesAlimera SciencesSIC Code 28,283NAICS Code 32,325Show more

Alimera Sciences Org Chart

PhoneEmail
AG
United States flag for contact location.

Director, Clinical Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Alimera Sciences your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Alimera Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Alimera Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alimera Sciences.

Alimera Sciences Tech Stack

A closer look at the technologies used by Alimera Sciences

Top Manufacturing Companies

Frequently Asked Questions Regarding Alimera Sciences

What is Alimera Sciences's official website?
Alimera Sciences's official website is www.alimerasciences.pt
What is Alimera Sciences's Revenue?
Alimera Sciences's revenue is $8 Million
What is Alimera Sciences's SIC code?
Alimera Sciences's SIC: 28,283
What is Alimera Sciences's NAICS code?
Alimera Sciences's NAICS: 32,325
How many employees does Alimera Sciences have?
Alimera Sciences has 11-50 employees
What industry does Alimera Sciences belong to?
Alimera Sciences is in the industry of: Manufacturing, Pharmaceuticals
What technology does Alimera Sciences use?
Some of the popular technologies that Alimera Sciences uses are: WooCommerce, WordPress.org, PHP, Google Font API
What does Alimera Sciences do?

Alimera Sciences is a global pharmaceutical company dedicated to developing innovative therapies that improve vision in chronic retinal diseases. The company focuses on conditions affecting the posterior segment of the eye, particularly the retina, aiming to address the inadequacies of current treatments that impact millions in an aging population.... Alimera strives to help patients see better for longer with fewer treatments by collaborating with the medical community and patient associations. Their mission is to be invaluable to patients, doctors, and partners concerned with retinal health.Read More

What are Alimera Sciences social media links?
Alimera Sciences Linkedin page Alimera Sciences Facebook page
Is Alimera Sciences a public company?
Alimera Sciences is private company therefore does not currently have an official ticker symbol
See more information about Alimera Sciences

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.